Clinical Trials Browser

OTHER × Gastric Adenocarcinoma × Trifluridine × Clear all

NCT04074343 2024-02-02

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

Phase 1 Completed

20 enrolled 9 charts

Gastrointestinal

Gastric Adenocarcinoma